Patrick J. Blatchford, Ph.D. - Publications

Affiliations: 
2007 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Biostatistics Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hu J, Blatchford PJ, Goldenberg NA, Kittelson JM. Group sequential designs for clinical trials with bivariate endpoints. Statistics in Medicine. 39: 3823-3839. PMID 33048360 DOI: 10.1002/Sim.8696  0.56
2019 Keith RL, Blatchford PJ, Merrick DT, Bunn PA, Bagwell B, Dwyer-Nield LD, Jackson MK, Geraci M, Miller YE. A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High Risk Current and Former Smokers. Cancer Prevention Research (Philadelphia, Pa.). PMID 31308004 DOI: 10.1158/1940-6207.Capr-19-0006  0.398
2018 Karam SD, Reddy K, Blatchford P, Waxweiler T, DeLouize AM, Oweida A, Somerset H, Marshall C, Young C, Davies KD, Kane M, Tan AC, Wang XJ, Jimeno A, Aisner DL, et al. Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30084837 DOI: 10.1158/1078-0432.Ccr-18-0467  0.32
2017 Keith R, Blatchford P, Franklin W, Bunn P, Bagwell B, Jackson M, Merrick D, Miller Y. P2.06-032 Oral Pioglitazone for the Chemoprevention of Lung Cancer in Current and Former Smokers Journal of Thoracic Oncology. 12: S1091. DOI: 10.1016/J.Jtho.2016.11.1525  0.333
2015 Merrick DT, Gao D, Miller YE, Keith RL, Baron AE, Feser WJ, Kennedy TC, Blatchford P, Braudrick S, Hirsch FR, Heasley LE, Bunn PA, Franklin WA. PERSISTENCE OF BRONCHIAL DYSPLASIA IS ASSOCIATED WITH DEVELOPMENT OF INVASIVE SQUAMOUS CELL CARCINOMA. Cancer Prevention Research (Philadelphia, Pa.). PMID 26542061 DOI: 10.1158/1940-6207.Capr-15-0305  0.323
2015 Goldenberg NA, Abshire T, Blatchford PJ, Fenton LZ, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos AC, Steg PG, Stence NV, Turpie AG, Schulman S. Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings. Journal of Thrombosis and Haemostasis : Jth. PMID 26118944 DOI: 10.1111/Jth.13038  0.573
2015 Kutner JS, Blatchford PJ, Taylor DH, Ritchie CS, Bull JH, Fairclough DL, Hanson LC, LeBlanc TW, Samsa GP, Wolf S, Aziz NM, Currow DC, Ferrell B, Wagner-Johnston N, Zafar SY, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. Jama Internal Medicine. 175: 691-700. PMID 25798575 DOI: 10.1001/Jamainternmed.2015.0289  0.346
2011 Keith RL, Blatchford PJ, Kittelson J, Minna JD, Kelly K, Massion PP, Franklin WA, Mao J, Wilson DO, Merrick DT, Hirsch FR, Kennedy TC, Bunn PA, Geraci MW, Miller YE. Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prevention Research (Philadelphia, Pa.). 4: 793-802. PMID 21636546 DOI: 10.1158/1940-6207.Capr-11-0057  0.606
2011 Keith RL, Wilson DO, Bunn PA, Miller YE, Blatchford PJ, Jackson MK, Kittelson JK, Franklin WA, Hirsch FR, Minna J, Mao J, Massion P. Abstract PL04-02: Oral iloprost for the chemoprevention of lung cancer: A multicenter, SPORE-initiated trial Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-Pl04-02  0.399
2011 Keith RL, Blatchford PJ, Kittelson JK, Jackson M, Franklin WA, Minna J, Kelly K, Mao J, Massion P, Wilson DO, Hirsch FR, Bunn PA, Geraci MW, Miller YE, Investigators LIT. Abstract LB-90: Oral iloprost improves endobronchial dysplasia in former smokers Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-90  0.386
2007 Miller YE, Blatchford P, Hyun DS, Keith RL, Kennedy TC, Wolf H, Byers T, Bunn PA, Lewis MT, Franklin WA, Hirsch FR, Kittelson J. Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2425-31. PMID 18006932 DOI: 10.1158/1055-9965.Epi-07-0220  0.564
Show low-probability matches.